ACTO Named a Luminary in Everest Group's "Innovation Watch: Agentic AI in Life Sciences Commercial 2026"

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

ACTO-Technologies-Inc

More Like This

PR Newswire associated0

ACTO Named Among Everest Group's Top 50™ Pharmaceutical Technology Providers for 2026

PR Newswire associated0

ACTO Unveils First Ever Role-based AI SuperAgents Purpose-Built to Orchestrate Work for Life Sciences Field Teams

PR Newswire associated0

ACTO Launches AI Agents to Accelerate Field Excellence in Life Sciences with Intelligent Workflow Automation

PR Newswire associated0

ACTO Achieves Veeva Gold Product Partner Status, Following a Nearly Decade-Long Collaboration Supporting Mutual Customer Success

PR Newswire associated0

ACTO APPOINTS FORMER J&J PRESIDENT TO ITS BOARD OF DIRECTORS

PR Newswire associated0

ACTO JOINS VEEVA AI PARTNER PROGRAM TO STRENGTHEN FIELD TEAM MESSAGING DURING FACE-TO-FACE HCP INTERACTIONS

PR Newswire associated0

ACTO ANNOUNCES NEXT-GEN LAICA™: THE MOST INTELLIGENT AND PERSONALIZED AI KNOWLEDGE ASSISTANT FOR PHARMA FIELD TEAMS

ACTO UNVEILS ACTOVERSE: A PARTNER SOLUTIONS MARKETPLACE DRIVING INNOVATION AND EFFICIENCY IN FIELD EXCELLENCE AT VEEVA COMMERCIAL SUMMIT EUROPE